Stay updated on Oral AT2101 in Gaucher Disease Clinical Trial
Sign up to get notified when there's something new on the Oral AT2101 in Gaucher Disease Clinical Trial page.

Latest updates to the Oral AT2101 in Gaucher Disease Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA Locations section was added with listings for California, Florida, Georgia, Iowa, Kansas, Massachusetts, and Ohio; California Locations, Florida Locations, Georgia Locations, Iowa Locations, Kansas Locations, Massachusetts Locations, and Ohio Locations references were removed, and the page revision updated to v3.3.3.SummaryDifference0.9%

- Check21 days agoNo Change Detected
- Check43 days agoChange DetectedSite revision updated from v3.2.0 to v3.3.2; no study content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedThe site-wide notice about government funding lapses and operating status has been removed, while core study details and eligibility information remain unchanged.SummaryDifference0.4%

- Check64 days agoChange DetectedThe new screenshot shows minor visual/layout updates to the Study Details page, including spacing and labeling tweaks. There are no substantive changes to the study data, sections, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check93 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference4%

- Check100 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Oral AT2101 in Gaucher Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral AT2101 in Gaucher Disease Clinical Trial page.